Recreational 3,4-methylenedioxy-N-methylamphetamine (MDMA) or ecstasy and self-focused compassion: Preliminary steps in the development of a therapeutic psychopharmacology of contemplative practices

Journal of Psychopharmacology

Volumn 29, Issue 9, 2015, Pages 961-970

  Kamboj, Sunjeev K ^a   Kilford, Emma J ^a   Minchin, Stephanie ^a   Moss, Abigail ^a   Lawn, Will ^a   Das, Ravi K ^a   Falconer, Caroline J ^a   Gilbert, Paul ^b   Curran, H Valerie ^a   Freeman, Tom P ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF DERBY   (United Kingdom)

Author keywords

compassion; compassion focused therapy; MDMA; psychotherapy; self criticism

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; RECREATIONAL DRUG; PSYCHEDELIC AGENT;

ADULT; ARTICLE; AVOIDANCE BEHAVIOR; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEPRESSION; DRUG USE; EMOTIONAL ATTACHMENT; EUPHORIA; FEMALE; HUMAN; IMAGERY; MALE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; PSYCHOPHARMACOLOGY; PSYCHOPHARMACOTHERAPY; SCORING SYSTEM; SELF COMPASSION; SELF CONCEPT; SELF CRITICISM; SELF FOCUSED COMPASSION; SOCIAL ATTITUDE; TREATMENT OUTCOME; AFFECT; DRUG EFFECTS; EMPATHY; PROCEDURES; PSYCHOTHERAPY;

ADULT; AFFECT; EMPATHY; FEMALE; HALLUCINOGENS; HUMANS; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PSYCHOPHARMACOLOGY; PSYCHOTHERAPY;

EID: 84942085059     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881115587143     Document Type: Article

References (57)

1. Australian Institute of Health and Welfare (2011) National Drug Strategy Household Survey report. Drug Statistics Series (25). Canberra: AIHW.
2. Bartal IB-A, Decety J, Mason P, (2011) Empathy and pro-social behavior in rats. Science 334: 1427-1430.
3. Bartholomew K,. (1990) Avoidance of intimacy: An attachment perspective. Journal of Social and Personal Relationships 7: 147-178.
4. Beck AT, Steer RA, Brown GK, (2005) Beck Depression Inventory. Manual, Swedish version. Sandviken: Psykologiförlaget.
5. Bedi G, Hyman D, de Wit H, (2010) Is ecstasy an empathogen? Effects of +/-3,4-methylenedioxymethamphetamine on prosocial feelings and identification of emotional states in others. Biological Psychiatry 68: 1134-1140.
6. Bedi G, Phan KL, Angstadt M, et al. (2009) Effects of MDMA on sociability and neural response to social threat and social reward. Psychopharmacology 207: 73-83.
7. Blatt SJ, (1974) Levels of object representation in anaclitic and introjective depression. Psychoanalytic Study of the Child 29: 107-157.
8. Braehler C, Gumley A, Harper J, et al. (2013) Exploring change processes in compassion focused therapy in psychosis: Results of a feasibility randomized controlled trial. British Journal of Clinical Psychology 52: 199-214.
9. Broadbear JH, Kabel D, Tracy L, et al. (2013) Oxytocinergic regulation of endogenous as well as drug-induced mood. Pharmacology Biochemistry and Behavior 119: 61-71.
10. Brunt TM, Koeter MW, Niesink RJ, et al. (2012) Linking the pharmacological content of ecstasy tablets to the subjective experiences of drug users. Psychopharmacology 220: 751-762.
11. Churchland PS, Winkielman P, (2012) Modulating social behavior with oxytocin: How does it work? What does it mean? Hormones and Behavior 61: 392-399.
12. Collins NL, (1996) Working models of attachment: Implications for explanation, emotion, and behavior. Journal of Personality and Social Psychology 71: 810-832.
13. Depue RA, Morrone-Strupinsky JV, (2005) A neurobehavioral model of affiliative bonding: Implications for conceptualizing a human trait of affiliation. Behavioral and Brain Sciences 28: 313-349.
14. Dumont GJ, Sweep FC, van der Steen R, et al. (2009) Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration. Social Neuroscience 4: 359-366.
15. Dumont GJ, Verkes RJ,. (2006) A review of acute effects of 3,4-methylenedioxymethamphetamine in healthy volunteers. Journal of Psychopharmacology 20: 176-187.
16. Falconer CJ, King JA, Brewin CR, (2015) Demonstrating mood repair with a situation-based measure of self-compassion and self-criticism. Psychology and Psychotherapy: Theory, Research and Practice. Epub ahead of print. DOI: 10.1111/papt.12056.
17. Falconer CJ, Slater M, Rovira A, et al. (2014) Embodying compassion: A virtual reality paradigm for overcoming excessive self-criticism. PLoS One 9: e111933.
18. Freeman TP, Morgan CJ, Vaughn-Jones J, et al. (2012) Cognitive and subjective effects of mephedrone and factors influencing use of a new legal high. Addiction 107: 792-800.
19. Gilbert P, (2000) Social mentalities: Internal social conflict and the role of inner warmth and compassion in cognitive therapy. In: Gilbert P, Bailey KG, (eds) Genes on the Couch: Explorations in Evolutionary Psychotherapy. New York, NY: Routledge, pp. 118-150.
20. Gilbert P, (2014) The origins and nature of compassion focused therapy. British Journal of Clinical Psychology 53: 6-41.
21. Gilbert P, Birchwood M, Gilbert J, et al. (2001) An exploration of evolved mental mechanisms for dominant and subordinate behaviour in relation to auditory hallucinations in schizophrenia and critical thoughts in depression. Psychological Medicine 31: 1117-1127.
22. Gilbert P, Clarke M, Hempel S, et al. (2004) Criticizing and reassuring oneself: An exploration of forms, styles and reasons in female students. British Journal of Clinical Psychology 43: 31-50.
23. Gilbert P, Irons C, (2005) Focused therapies and compassionate mind training for shame and self-attacking. In Gilbert P, (ed), Compassion: Conceptualisations, Research and Use in Psychotherapy. Hove: Routledge, pp. 263-325.
24. Gilbert P, McEwan K, Matos M, et al. (2011) Fears of compassion: Development of three self-report measures. Psychology and Psychotherapy: Theory, Research and Practice 84: 239-255.
25. Gilbert P, McEwan K, Mitra R, et al. (2008) Feeling safe and content: A specific affect regulation system? Relationship to depression, anxiety, stress, and self-criticism. Journal of Positive Psychology 3: 182-191.
26. Green AR, Mechan AO, Elliott JM, et al. (2003) The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy). Pharmacological Reviews 55: 463-508.
27. Griffiths RR, Johnson MW, Richards WA, et al. (2011) Psilocybin occasioned mystical-type experiences: Immediate and persisting dose-related effects. Psychopharmacology 218: 649-665.
28. Hofmann SG, Grossman P, Hinton DE, (2011) Loving-kindness and compassion meditation: Potential for psychological interventions. Clinical Psychology Review 31: 1126-1132.
29. Kaliman P, Alvarez-Lopez MJ, Cosin-Tomas M, et al. (2014) Rapid changes in histone deacetylases and inflammatory gene expression in expert meditators. Psychoneuroendocrinology 40: 96-107.
30. Laithwaite H, OHanlon M, Collins P, et al. (2009) Recovery after psychosis (RAP): A compassion focused programme for individuals residing in high security settings. Behavioural and Cognitive Psychotherapy 37: 511-526.
31. Lassri D, Soffer-Dudek N, Lerman SF, et al. (2013) Self-criticism confers vulnerability to psychopathology in the face of perceived stress related to missile attacks: Three longitudinal studies. International Journal of Cognitive Therapy 6: 221-234.
32. Leneghan S, (2013) The varieties of ecstasy experience: A phenomenological ethnography. Journal of Psychoactive Drugs 45: 347-354.
33. Linehan M, (1993) Cognitive-Behavioral Treatment of Borderline Personality Disorder. New York: Guilford Press.
34. Lucre KM, Corten N, (2013) An exploration of group compassion-focused therapy for personality disorder. Psychology and Psychotherapy: Theory, Research and Practice 86: 387-400.
35. Lutz A, Brefczynski-Lewis J, Johnstone T, et al. (2008) Regulation of the neural circuitry of emotion by compassion meditation: Eeffects of meditative expertise. PLoS One 3: e1897.
36. Majumder I, White JM, Irvine RJ, (2012) Antidepressant-like effects of ecstasy in subjects with a predisposition to depression. Addictive Behaviors 37: 1189-1192.
37. Mikulincer M, Shaver PR, Gillath O, et al. (2005) Attachment, caregiving, and altruism: Boosting attachment security increases compassion and helping. Journal of Personality and Social Psychology 89: 817-839.
38. Mithoefer MC, Wagner MT, Mithoefer AT, et al. (2011) The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: The first randomized controlled pilot study. Journal of Psychopharmacology 25: 439-452.
39. Mithoefer MC, Wagner MT, Mithoefer AT, et al. (2013) Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: A prospective long-term follow-up study. Journal of Psychopharmacology 27: 28-39.
40. Moonzwe LS, Schensul JJ, Kostick KM, (2011) The role of MDMA (ecstasy) in coping with negative life situations among urban young adults. Journal of Psychoactive Drugs 43: 199-210.
41. Morgan CJ, Noronha LA, Muetzelfeldt M, et al. (2013) Harms and benefits associated with psychoactive drugs: Findings of an international survey of active drug users. Journal of Psychopharmacology 27: 497-506.
42. Northoff G, (2007) Psychopathology and pathophysiology of the self in depression-neuropsychiatric hypothesis. Journal of Affective Disorders 104: 1-14.
43. Nutt DJ, King LA, Nichols DE, (2013) Effects of Schedule I drug laws on neuroscience research and treatment innovation. Nature Reviews. Neuroscience 14: 577-585.
44. Oehen P, Traber R, Widmer V, et al. (2013) A randomized, controlled pilot study of MDMA (±3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic post-traumatic stress disorder (PTSD). Journal of Psychopharmacology 27: 40-52.
45. Parrott AC, (2013) Human psychobiology of MDMA or ecstasy: An overview of 25 years of empirical research. Human Psychopharmacology 28: 289-307.
46. Pinto-Gouveia J, Castilho P, Matos M, et al. (2013) Centrality of shame memories and psychopathology: The mediator effect of self-criticism. Clinical Psychology: Science and Practice 20: 323-334.
47. Power M, (2013) Drugs 2.0: The Web Revolution Thats Changing how the World Gets High. London, UK: Portobello Books.
48. Rockliff H, Gilbert P, McEwan K, et al. (2008) A pilot exploration of heart rate variability and salivary cortisol responses to compassion-focused imagery. Journal of Clinical Neuropsychiatry 5: 132-139.
49. Rockliff H, Karl A, McEwan K, et al. (2011) Effects of intranasal oxytocin on compassion focused imagery. Emotion 11: 1388-1396.
50. Rogers G, Elston J, Garside R, et al. (2009) The harmful health effects of recreational ecstasy: A systematic review of observational evidence. Health Technology Assessment 13: xii-338.
51. Schanche E, (2013) The transdiagnostic phenomenon of self-criticism. Psychotherapy 50: 316-321.
52. Sessa B,. (2014) Why Psychiatry needs psychedelics and psychedelics need psychiatry. Journal of Psychoactive Drugs 46: 57-62.
53. Sumnall HR, Cole JC, Jerome L, (2006) The varieties of ecstatic experience: An exploration of the subjective experiences of ecstasy. Journal of Psychopharmacology 20: 670-682.
54. Thompson ER, (2007) Development and validation of an internationally reliable short-form of the positive and negative affect schedule (PANAS). Journal of Cross-Cultural Psychology 38: 227-242.
55. Wallace BA, Shapiro SL, (2006) Mental balance and well-being: Building bridges between Buddhism and Western psychology. American Psychologist 61: 690-701.
56. Watson L, Beck J, (1991) New age seekers: MDMA use as an adjunct to spiritual pursuit. Journal of Psychoactive Drugs 23: 261-270.
57. Weng HY, Fox AS, Shackman AJ, et al. (2013) Compassion training alters altruism and neural responses to suffering. Psychological Science 24: 1171-1180.